Page 1 of Clinical Trials for Mannkind Corporation [SPONSOR-COLLABORATORS], 41 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
To Compare the Effect of Inhaled Insulin With Subcutaneously Injected Insulin in Subjects With Type 2 Diabetes Mellitus.
Last Updated: October 12, 2009
Condition(s): Diabetes Mellitus, Type 2
2
Completed
Study of the Efficacy and Safety of Inhaled Technosphere Insulin in Patients With Type 2 Diabetes
Last Updated: April 27, 2012
Condition(s): Type 2 Diabetes Mellitus
3
Terminated
Clinical Trial Evaluating the Efficacy and Safety of Technosphere® Inhalation Insulin (TI) Inhalation Powder Using the Gen2 Inhaler
Last Updated: May 17, 2012
Condition(s): Type 2 Diabetes
4
Completed
Safety and Efficacy of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder)When an Optimal Dose is Taken With Varied Carbohydrate Intake
Last Updated: July 12, 2011
Condition(s): Diabetes Mellitus, Type 2; Diabetes Mellitus, Type 1
5
Completed
Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes
Last Updated: October 1, 2009
Condition(s): Diabetes, Type I
6
Completed
Clamp Study Comparing Inhalation of Technosphere®/Insulin in Smokers and Non-Smokers With Type 2 Diabetes
Last Updated: July 7, 2009
Condition(s): Diabetes Type 2
7
Recruiting
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
Last Updated: February 28, 2011
Condition(s): Diabetic Type 1 With Obstructive Pulmonary Disease; Diabetic Type 2 With Obstructive Pulmonary Disease; Asthma; COPD; Diabetes Mellitus, Insulin-Dependent; Diabetes Mellitus, Non-Insulin-Dependent; Indeterminate Obstructive Lung Disease
8
Completed
Pharmacokinetic Study in Healthy Volunteers
Last Updated: June 6, 2011
Condition(s): Healthy Volunteers
9
Completed
Bioavailability of Technosphere® Insulin Versus Subcutaneous Regular Human Insulin in Type 2 Diabetes
Last Updated: June 28, 2011
Condition(s): Type 2 Diabetes Mellitus
10
Completed
A Study Designed to Determine if the Pharmacokinetic Disposition of Inhaled Insulin Exposure is the Same for Asthmatics and Non-asthmatics
Last Updated: October 1, 2009
Condition(s): Asthma; Diabetes Mellitus
11
Completed
Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks
Last Updated: August 3, 2010
Condition(s): Diabetes Type 1
12
Completed
An Open-label, Multi-center, International, Three-year, Safety and Tolerability 'Follow on' Trial
Last Updated: October 1, 2009
Condition(s): Type 2 Diabetes Mellitus
13
Terminated
Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma
Last Updated: May 3, 2012
Condition(s): Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Asthma
14
Completed
Vaccine Therapy in Treating Patients With Stage IV Melanoma
Last Updated: May 11, 2011
Condition(s): Melanoma (Skin)
15
Terminated
Pulmonary Function Substudy for Subjects Enrolled in Studies MKC-TI-161, MKC-TI-162 or MKC-TI-166
Last Updated: July 14, 2011
Condition(s): Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus
16
Completed
A 2-Month Safety Follow-Up Trial
Last Updated: October 1, 2009
Condition(s): Type 1 Diabetes; Type 2 Diabetes
17
Completed
18-Week, Randomized, Double-blind, Placebo Controlled, Forced Titration Study of Patients With Type 2 Diabetes
Last Updated: April 27, 2012
Condition(s): Type 2 Diabetes Mellitus
18
Completed
Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes
Last Updated: October 1, 2009
Condition(s): Diabetes, Type I; Diabetes Type 2
19
Completed
A Study Designed to Determine the Safety and Pharmacological Response ofMKC253 Inhalation Powder in Adults With Type 2 Diabetes Mellitus
Last Updated: September 22, 2008
Condition(s): Diabetes Mellitus, Type 2
20
Completed
Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up
Last Updated: October 1, 2009
Condition(s): Diabetes Type 2

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Mannkind+Corporation

Page 1 of Clinical Trials for Mannkind Corporation [SPONSOR-COLLABORATORS], 41 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About